A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Lantheus Holdings, Inc. stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 17,421 shares of LNTH stock, worth $1.59 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
17,421
Previous 333,716 94.78%
Holding current value
$1.59 Million
Previous $26.8 Million 92.87%
% of portfolio
0.01%
Previous 0.07%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$77.7 - $123.62 $24.6 Million - $39.1 Million
-316,295 Reduced 94.78%
17,421 $1.91 Million
Q2 2024

Aug 14, 2024

BUY
$58.87 - $83.05 $19.6 Million - $27.7 Million
333,716 New
333,716 $26.8 Million
Q4 2023

Feb 14, 2024

BUY
$55.6 - $77.89 $6.87 Million - $9.63 Million
123,638 New
123,638 $7.67 Million
Q1 2023

May 15, 2023

SELL
$47.76 - $82.86 $1.47 Million - $2.56 Million
-30,874 Reduced 5.61%
519,404 $42.9 Million
Q4 2022

Feb 14, 2023

BUY
$48.76 - $77.67 $26.8 Million - $42.7 Million
550,278 New
550,278 $28 Million
Q2 2022

Aug 15, 2022

SELL
$55.54 - $72.65 $15.1 Million - $19.7 Million
-271,418 Reduced 29.74%
641,311 $42.3 Million
Q1 2022

May 16, 2022

BUY
$24.28 - $56.64 $22.2 Million - $51.7 Million
912,729 New
912,729 $50.5 Million
Q3 2021

Nov 15, 2021

SELL
$24.23 - $28.59 $8.89 Million - $10.5 Million
-366,716 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$19.51 - $27.64 $7.15 Million - $10.1 Million
366,716 New
366,716 $10.1 Million
Q3 2018

Nov 14, 2018

SELL
$13.1 - $16.35 $968,090 - $1.21 Million
-73,900 Closed
0 $0
Q2 2018

Aug 14, 2018

SELL
$13.65 - $18.7 $106,470 - $145,860
-7,800 Reduced 9.55%
73,900 $1.08 Million
Q1 2018

May 15, 2018

BUY
$14.85 - $24.3 $1.21 Million - $1.99 Million
81,700 New
81,700 $1.3 Million

Others Institutions Holding LNTH

About Lantheus Holdings, Inc.


  • Ticker LNTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 68,741,904
  • Market Cap $6.28B
  • Description
  • Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...
More about LNTH
Track Steven Cohen's Portfolio

Track Steven Cohen Portfolio

Follow Steven Cohen (Point72 Asset Management, L.P.) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.